AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Hugin)
Following a Request for Proposal issued in 2007 with the intent to procure an MVA-based, third generation smallpox vaccine, Public Works and Government Services Canada, on behalf of the Canadian Department of National Defence, has awarded a contract to Bavarian Nordic for the delivery of IMVAMUNE.
The Canadian authorities intend to use IMVAMUNE as part of the country's bio-preparedness programme.
The contract provides for the delivery of 20,000 doses of IMVAMUNE and payment for the application process to support the use of IMVAMUNE in an emergency under the Canadian Government's Special Access Programme. The delivery will take place in 2009.
The contract also provides for the optional purchase of an additional 180,000 doses of IMVAMUNE as well as payment for investigating the requirements for obtaining a licensure of the vaccine in Canada.
Hereby, the Government of Canada and Bavarian Nordic have entered into a long term contract.
The order does not change Bavarian Nordic's previously announced financial guidance for 2008.